The Future of Treating Small Cell Lung Cancer
Kartik Konduri, MD, comments on the future of treating extensive-stage small cell lung cancer and provides advice for community oncologists treating patients with the disease.
Lurbinectedin in the Treatment of Small Cell Lung Cancer
Kartik Konduri, MD, describes the phase 2 basket trial of lurbinectedin in the treatment of extensive-stage small cell lung cancer.
Treatment Options in Small Cell Lung Cancer
Kartik Konduri, MD, discusses treatment options for extensive-stage small cell lung cancer.
Evaluation of a Patient with Small Cell Lung Cancer
Kartik Konduri, MD, evaluates the case of a 68-year-old woman with extensive-stage small cell lung cancer.
A 68-Year-Old Woman with Small-Cell Lung Cancer
Kartik Konduri, MD, reviews the case of a 68-year-old woman with small-cell lung cancer.